$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
This paper describes a versatile method for single cell fate mapping based on the photoactivation of caged fluorescein-dextran. Uncaging of caged fluorescein-dextran in single cells is achieved using two-photon absorption from a Mai Tai femtosecond laser coupled to the Zeiss LSM 510 META confocal microscope. Uncaged fluorescein-dextran in photoactivated cells is rapidly visualized using a simple immunohistochemistry procedure.
In this protocol the two-photon absorption wavelength for photoactivation of caged fluorescein-dextran is 740 nm. This wavelength was experimentally determined by photoactivating caged fluorescein-dextran injected wildtype embryos. The laser excitation wavelength was varied from 600 to 800 nm, and the presence or absence of fluorescein fluorescence post-activation was qualitatively determined. We found that 740 nm produced the strongest fluorescein signal following activation. Ideally, 740 nm should work for all model systems; however, we advise testing a range of wavelengths to determine the optimal two-photon excitation wavelength for your sample.
In caged fluorescein-dextran injected wildtype embryos, for each two-photon excitation wavelength tested we also varied the average laser power. For an excitation wavelength of 740 nm, an average laser power of 47 mW produced a stronger fluorescein signal at the activated region in comparison to lower average laser powers. Higher average laser powers did not produce stronger fluorescein signals, but induced ablation of the tissue. Since femtosecond laser pulses are efficient at ablating biological tissue15, we recommend determining the threshold average laser power for photoactivation that avoids tissue ablation.
Two-photon absorption occurs within a small interaction volume. To ensure proper activation of caged fluorescein-dextran, the cell must be brought into proper focus. In the above protocol, GFP positive cells were simultaneously imaged under white light to confirm cell focus. Therefore, white light acquisition in addition to other channels is advisable. After confirming cell focus, our protocol suggests magnifying the activated cell. A zoom factor of 50 to 70 is suggested, however, this value depends on the size of the chosen cell. Increasing the zoom isolates the activated cell from adjacent cells, and limits the scan area for two-photon activation. Ideally, the scan area should cover a large area of the cell.
Detection of single activated cells requires that the background staining be minimal. In the above immunodetection protocol it is important that the sample is blocked in blocking buffer for 5 to 6 hours (step 4.13). When developing with NBT/BCIP, uncaged fluorescein-dextran should become visible in 10 to 20 mins. If background staining is strong, we suggest a longer blocking time and additional washes to remove the antibody (step 4.17).
Figures 1 and 2 provide representative results of photoactivation and immunodetection. In Figure 1, early 1- to 2-cell stage wildtype embryos were injected with caged fluorescein-dextran. The embryos were raised to mid somitogenesis and mounted in low melting agarose in the lateral orientation. Figure 1(a,b) depict brightfield and fluorescent images of the embryo before photoactivation. Evidence that the embryo remained uncaged is demonstrated by the absence of fluorescein fluorescence in Figure 1(b). A small region within a somite was activated with a wavelength of 740 nm for 31 secs using an average laser power of 47 mW, Figure 1(c; arrow). Post-activation, two-photon uncaging of fluorescein-dextran occurred as shown by the fluorescence from the activated area, Figure 1(d; arrow). Activation was not accompanied by laser ablation, as the somitic tissue remained intact, Figure 1(c). Figure 2 demonstrates the immunodetection of uncaged fluorescein-dextran. A small region in the lateral plate mesoderm of a 10-somite stage embryo was photoactivated using the same laser parameters as mentioned in Figure 1. The embryo was raised and processed using steps 4.1 through 4.20. The arrow in Figure 2 locates the region activated, as indicated by the accumulation of blue precipitate. Only the activated location is clearly detected without interfering background staining.
Preparation of Solutions:
1 X PBT (1 L)
100 mL 10 X PBS
2 g BSA
10 mL 20 % Tween
10 X PBS (1 L)
80 g NaCl
2 g KCl
6.1 g Na2HPO4
1.9 g KH2PO4
ddH2O to 1 L
pH to 7.3
4 % Paraformaldehyde (160 mL)
32 % Paraformaldehyde (two 10 mL vials)
8 mL 20 X PBS
132 mL ddH2O
AP Buffer ( 50 mL)
1 mL 5 M NaCl
2.5 mL 1 M MgCl2
5 mL 1 M Tris pH 9.5
250 μL 20 % Tween
41.25 mL ddH2O
Antibody solution (for 1 sample)
5.5 μL Acetone powder
40 μL PBT
0.8 μL LS
0.1 μL Anti-fluorescein-AP antibody
2 % LS (360 μL for 1 sample)
7.2 μL 100 % LS
352.8 μL PBT
1 X Danieau media (1 L)‡
11.6 mL 5 M NaCl
700 μL 1 M KCl
400 μL 1 M MgSO4
600 μL 1 M Ca(NO3)2
5 mL 1 M HEPES
ddH2O to 1 L
pH adjust to 7.6
‡ Danieau is an ideal salt solution for rearing dechorionated zebrafish embryos. Other media may be used, provided they are isotonic solutions with properly osmolarity (~ 300 mOsm for zebrafish)
NBT stock (1 mL)
50 mg Nitro Blue Tetrazolium
0.7 mL dimethyl formamide anhydride
0.3 mL ddH2O
BCIP stock (1 mL)
50 mg 5-bromo-4-chloro-3-indolyl phosphate
1 mL dimethyl formamide anhydride
NBT/BCIP developing solution
1 mL AP buffer
4.5 μL NBT stock
3.5 μL BCIP stock
Acetone powder
- Select 20 adult fish and freeze them in liquid nitrogen.
- Grind the frozen fish with a mortar and pestle to a powder.
- Transfer the fish powder into a 50 mL conical tube.
- Fill the conical tube with 100 % acetone. Vortex the tube.
- Spin the tube at max rpm for 10 mins. Discard the supernatant.
- Wash the pellet another 3 times in 100 % acetone and spin the tube at max rpm for 10 mins. By the last wash the supernatant should appear clear.
- Add 100 % acetone to the pellet again and let the tube stand at room temperature. The more dense particles will settle, while the finer particles will remain in suspension.
- Decant the fine particles into a new tube. Aliquot the powder solution into separate tubes and store them at -20 °C.